- CA$7.15bn
- CA$9.91bn
- CA$3.49bn
Annual balance sheet for Apotex Health, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Cash | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 421 | 78 | 57 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 936 | 1,011 | 1,058 |
| Total Inventory | |||
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 2,444 | 2,323 | 2,173 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 1,110 | 1,142 | 1,131 |
| Net Goodwill | |||
| Net Intangible Assets | |||
| Other Long Term Assets | |||
| Total Assets | 4,038 | 4,852 | 4,544 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 1,337 | 1,668 | 1,449 |
| Long Term Debt | |||
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Deferred Income Tax | |||
| Total Other Liabilities | |||
| Total Liabilities | 3,306 | 4,561 | 5,102 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Other Equity | |||
| Total Equity | 733 | 291 | -558 |
| Total Liabilities & Shareholders' Equity | 4,038 | 4,852 | 4,544 |
| Total Common Shares Outstanding |